StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) stock

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3090% above fair value
$292.82−1.73 (-0.59%)

Close on Nov 17, 2026Market cap $517.45BP/E 82.7Yield 2.27%

AbbVie market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

AbbVie's market cap was $523.07B on Nov 11, 2026, against $403.66B a year earlier. Over the last 5 years it ranged from $238.59B to $523.07B, with a median of $315.06B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$523.07B+29.1%
2025Dec 31, 2025$405.06B+28.6%
2024Dec 31, 2024$315.06B+14.6%
2023Dec 29, 2023$275.03B-4.3%
2022Dec 30, 2022$287.26B+19.4%
2021Dec 31, 2021$240.64B+40.5%
2020Dec 31, 2020$171.23B+30.0%
2019Dec 31, 2019$131.73B-9.1%
2018Dec 31, 2018$144.95B-6.8%
2017Dec 29, 2017$155.49B+51.9%
2016Dec 30, 2016$102.38B+6.1%
2015Dec 31, 2015$96.53B-8.3%
2014Dec 31, 2014$105.31B+24.7%
2013Dec 31, 2013$84.44B–

More AbbVie figures

See a number that looks wrong?